[AO-02] Oral Presentation Award Nominee Session (Clinical Research)

[AO-02-3] Nodal ATP1A2/3 antibody is a new pathogenic marker for juvenile onset NMOSD/CCPD and progressive MS

Xu Zhang¹, Jun-ichi Kira^1,2,3, Mikio Mitsuishi¹, Daisuke Tsuchimoto⁴, Maimaitijiang Guzailiayi¹, Tomohiro Imamura^1,3, Ayako Sakoda^2,3, Yuri Nakamura^1,2,3 (1.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Okawa, Japan, 2.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan, 3.School of Pharmacy at Fukuoka, International University of Health and Welfare, Okawa, Japan, 4.Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan)